journal article·2022-06

Modulation of Tumor Vasculature Network: Key Strategies

Mohammad Taleb, Niloufar Mohammadkhani, Farbod Bahreini, Muhammad Ovais, Guangjun Nie

Small Structures· Volume 3· Issue 6
Publisher page

Abstract

Tumor cells, owing to their relentless division, require increased nutrient supply. This is made possible by angiogenesis, that is, the formation of new blood vessels increases the blood flow toward tumor cells, thereby promoting the supply of oxygen and vital nutrients required for the proliferation of tumor cells. Decreasing the blood flow to the tumor cells can effectively halt tumor progression and possibly cure cancer. However, practically, the mechanism is not as straightforward as it seems. In this review, the role of angiogenesis is focused on in the development of tumors and cancer metastasis and the potential of tumor vascular normalization for the reduction of angiogenesis, which results in the suppression of tumor cells. An insight into various strategies, including pharmacological inhibition of angiogenesis, genetic models, and nanoparticle‐based novel treatment strategies for vascular normalization, is provided. In addition, the effect of vessel normalization and tumor microenvironment modulation on the delivery of nanoparticle‐based drugs to the target tumor cells is discussed. The critical role of monitoring vascular normalization is also highlighted, without which selecting the most efficient strategy for tumor vascular normalization is possible. Therefore, efficiently combating cancer and its devastating effects remains an unsolved puzzle.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Angiogenesis and VEGF in Cancer · Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety CAS Center of Excellence in Nanoscience National Center for Nanoscience and Technology Beijing 100190 P. R. China

Center of Materials Science and Optoelectronics Engineering University of Chinese Academy of Sciences Beijing 100049 P. R. China

Department of Clinical Biochemistry School of Medicine Shahid Beheshti University of Medical Sciences Tehran 1985717443 Iran

Department of Biochemistry Faculty of Biological Sciences Tarbiat Modares University Tehran 1985717443 Iran

References (100+)

Show source-provided references
1. 10.3390/cancers1103031610.3390/cancers11030316 ↗
2. 10.1146/annurev-physiol-020518-11470010.1146/annurev-physiol-020518-114700 ↗
3. 10.1016/j.trecan.2018.02.00510.1016/j.trecan.2018.02.005 ↗
4. 10.1016/j.addr.2016.04.02510.1016/j.addr.2016.04.025 ↗
5. 10.1016/j.jconrel.2015.04.00610.1016/j.jconrel.2015.04.006 ↗
6. 10.1021/acs.accounts.9b0028310.1021/acs.accounts.9b00283 ↗
7. 10.1002/adhm.20210005110.1002/adhm.202100051 ↗
8. 10.1002/advs.20180207010.1002/advs.201802070 ↗
9. 10.1093/oxfordjournals.annonc.a05904310.1093/oxfordjournals.annonc.a059043 ↗
10. 10.1007/s00247005029610.1007/s002470050296 ↗
11. 10.1038/nm0603-71310.1038/nm0603-713 ↗
12. Dvorak H. F. · Am. J. Pathol. · 1988 · 133 · 95
13. 10.1158/0008-5472.CAN-04-269110.1158/0008-5472.CAN-04-2691 ↗
14. 10.1016/S0002-9440(10)63540-710.1016/S0002-9440(10)63540-7 ↗
15. Colorado P. C. · Cancer Res. · 2000 · 60 · 2520
16. 10.1038/nrc109410.1038/nrc1094 ↗
17. 10.1016/S0002-9440(10)64920-610.1016/S0002-9440(10)64920-6 ↗
18. Eberhard A. · Cancer Res. · 2000 · 60 · 1388
19. 10.1172/JCI20031854910.1172/JCI200318549 ↗
20. 10.1172/JCI20042271610.1172/JCI200422716 ↗
21. 10.1126/science.284.5422.199410.1126/science.284.5422.1994 ↗
22. 10.1371/journal.pcbi.100039410.1371/journal.pcbi.1000394 ↗
23. 10.1152/physrev.00038.201010.1152/physrev.00038.2010 ↗
24. 10.1056/NEJM19600616262240110.1056/NEJM196006162622401 ↗
25. 10.1016/j.cdtm.2017.01.00210.1016/j.cdtm.2017.01.002 ↗
26. 10.1038/nm0603-68510.1038/nm0603-685 ↗
27. Martin J. D. · Cold Spring Harbor Perspect. Med. · 2016 · 6
28. 10.1038/nrd.2017.410.1038/nrd.2017.4 ↗
29. 10.1038/nm0901-98710.1038/nm0901-987 ↗
30. 10.1126/science.110481910.1126/science.1104819 ↗
31. 10.1002/adhm.20190028310.1002/adhm.201900283 ↗
32. 10.1073/pnas.191976411710.1073/pnas.1919764117 ↗
33. 10.1073/pnas.93.25.1476510.1073/pnas.93.25.14765 ↗
34. 10.1007/978-3-540-33177-3_2310.1007/978-3-540-33177-3_23 ↗
35. 10.1038/nm98810.1038/nm988 ↗
36. 10.1158/1078-0432.CCR-07-027810.1158/1078-0432.CCR-07-0278 ↗
37. Tolnay E. · Oncol. Lett. · 2019 · 17 · 1750
38. 10.1002/jmri.2004910.1002/jmri.20049 ↗
39. 10.1016/j.ijrobp.2009.12.01010.1016/j.ijrobp.2009.12.010 ↗
40. 10.1158/0008-5472.CAN-10-015310.1158/0008-5472.CAN-10-0153 ↗
41. 10.1016/S0002-9440(10)63273-710.1016/S0002-9440(10)63273-7 ↗
42. 10.4161/cbt.7.7.599710.4161/cbt.7.7.5997 ↗
43. 10.1073/pnas.95.16.934910.1073/pnas.95.16.9349 ↗
44. 10.1038/nrc252410.1038/nrc2524 ↗
45. 10.1016/j.ccr.2006.10.01810.1016/j.ccr.2006.10.018 ↗
46. 10.1016/j.ccr.2010.11.00110.1016/j.ccr.2010.11.001 ↗
47. 10.1158/0008-5472.CAN-04-007410.1158/0008-5472.CAN-04-0074 ↗
48. 10.1158/1078-0432.CCR-10-245610.1158/1078-0432.CCR-10-2456 ↗
49. Hansen-Algenstaedt N. · Cancer Res. · 2000 · 60 · 4556
50. 10.1158/1078-0432.CCR-09-009010.1158/1078-0432.CCR-09-0090 ↗
51. 10.1038/7472510.1038/74725 ↗
52. 10.1126/science.286.5449.251110.1126/science.286.5449.2511 ↗
53. 10.1158/1078-0432.CCR-09-307310.1158/1078-0432.CCR-09-3073 ↗
54. 10.1158/0008-5472.CAN-05-092310.1158/0008-5472.CAN-05-0923 ↗
55. 10.1016/S0002-9440(10)63905-310.1016/S0002-9440(10)63905-3 ↗
56. 10.1021/nn501081510.1021/nn5010815 ↗
57. 10.3390/biomedicines903030510.3390/biomedicines9030305 ↗
58. 10.1038/nature0742410.1038/nature07424 ↗
59. 10.1172/JCI3133410.1172/JCI31334 ↗
60. 10.1215/15228517-2008-08810.1215/15228517-2008-088 ↗
61. 10.1158/1078-0432.CCR-07-454410.1158/1078-0432.CCR-07-4544 ↗
62. 10.1016/j.ccr.2010.11.00910.1016/j.ccr.2010.11.009 ↗
63. 10.1016/j.cell.2007.08.03810.1016/j.cell.2007.08.038 ↗
64. 10.1016/j.cell.2010.02.03910.1016/j.cell.2010.02.039 ↗
65. 10.1016/j.cell.2010.01.03310.1016/j.cell.2010.01.033 ↗
66. 10.1016/j.cell.2010.02.03910.1016/j.cell.2010.02.039 ↗
67. 10.1053/j.seminoncol.2003.08.01310.1053/j.seminoncol.2003.08.013 ↗
68. 10.1056/NEJMoa06188410.1056/NEJMoa061884 ↗
69. 10.1200/JCO.2009.27.772310.1200/JCO.2009.27.7723 ↗
70. 10.3389/fonc.2018.0032010.3389/fonc.2018.00320 ↗
71. 10.1007/s00262-007-0441-x10.1007/s00262-007-0441-x ↗
72. 10.1186/s12974-019-1563-810.1186/s12974-019-1563-8 ↗
73. 10.1158/1078-0432.CCR-06-155810.1158/1078-0432.CCR-06-1558 ↗
74. 10.1038/nbt132310.1038/nbt1323 ↗
75. 10.1158/0008-5472.CAN-12-232510.1158/0008-5472.CAN-12-2325 ↗
76. 10.4161/2162402X.2014.98976410.4161/2162402X.2014.989764 ↗
77. 10.1182/blood.V88.2.667.bloodjournal88266710.1182/blood.V88.2.667.bloodjournal882667 ↗
78. 10.1096/fj.05-4493com10.1096/fj.05-4493com ↗
79. 10.1007/s00280-014-2647-x10.1007/s00280-014-2647-x ↗
80. 10.1200/jco.2010.28.15_suppl.506410.1200/jco.2010.28.15_suppl.5064 ↗
81. 10.1073/pnas.151880811210.1073/pnas.1518808112 ↗
82. 10.1016/j.ccell.2016.10.01810.1016/j.ccell.2016.10.018 ↗
83. 10.1016/j.ccr.2011.01.00510.1016/j.ccr.2011.01.005 ↗
84. 10.1158/0008-5472.CAN-11-219410.1158/0008-5472.CAN-11-2194 ↗
85. 10.1016/j.jconrel.2018.05.00210.1016/j.jconrel.2018.05.002 ↗
86. 10.3389/fimmu.2017.0148310.3389/fimmu.2017.01483 ↗
87. 10.2217/nnm.12.12810.2217/nnm.12.128 ↗
88. 10.3389/fonc.2019.0122710.3389/fonc.2019.01227 ↗
89. 10.1038/nnano.2012.4510.1038/nnano.2012.45 ↗
90. 10.1021/acsnano.5b0202810.1021/acsnano.5b02028 ↗
91. 10.1016/j.nano.2012.07.00210.1016/j.nano.2012.07.002 ↗
92. 10.1073/pnas.060242710310.1073/pnas.0602427103 ↗
93. 10.1016/j.biomaterials.2018.05.03410.1016/j.biomaterials.2018.05.034 ↗
94. 10.3389/fmedt.2019.0000110.3389/fmedt.2019.00001 ↗
95. 10.1016/j.jconrel.2012.03.02010.1016/j.jconrel.2012.03.020 ↗
96. 10.3109/21691401.2014.95363310.3109/21691401.2014.953633 ↗
97. 10.1016/j.jconrel.2019.04.02510.1016/j.jconrel.2019.04.025 ↗
98. 10.1038/srep3061910.1038/srep30619 ↗
99. 10.1016/j.actbio.2018.06.03410.1016/j.actbio.2018.06.034 ↗
100. 10.2147/IJN.S12880210.2147/IJN.S128802 ↗